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Fifty coronary angiograms were reviewed by two interventional cardiologists independently. 
Knowledge of vFFR led to a change in management in 27%. VCI and a stent sizing tool led to a 
change in recommended stent size in 48%. Disclosure of vFFR and VCI increased operator confidence 
(p<0.001). Twelve cases were reviewed by six additional operators. There was significant variation in 








































Background: Using fractional flow reserve (FFR) to guide percutaneous coronary intervention for 




used. Virtual FFR (vFFR, computed from angiographic images) permits physiological assessment 
without a pressure wire and can be extended to virtual coronary intervention (VCI) facilitating 
treatment planning. This study investigated the effect of adding vFFR and VCI to angiography in 
patient assessment and management. 
Methods: Two cardiologists independently reviewed clinical data and angiograms of 50 patients 
undergoing invasive management of coronary syndromes, and their management plans were 
recorded. The vFFRs were computed and disclosed, and the cardiologists submitted revised plans. 
Then, using VCI, the physiological results of various interventional strategies were shown, and 
further revision was invited.  
Results: Disclosure of vFFR led to a change in strategy in 27%.  VCI led to a change in stent size in 
48%. Disclosure of vFFR and VCI resulted in an increase in operator confidence in their decision. 
Twelve cases were reviewed by six additional cardiologists. There was limited agreement in the 
management plans between cardiologists based upon either angiography (kappa=0.31) or vFFR 
(kappa=0.39).  
Conclusions: vFFR has the potential to alter decision making, and VCI can guide stent sizing. 
However, variability in management strategy remains considerable between operators, even when 










CABG  Coronary artery bypass graft 
CMR  Cardiac magnetic resonance 
CMVR  Coronary Microvascular Resistance 
CTCA  Computed tomography coronary angiography 
ECG  Electrocardiogram 
FFR  Fractional Flow Reserve 
NSTE-ACS Non ST-segment Elevation Acute Coronary Syndromes 
OMT  Optimal medical therapy 
PCI  Percutaneous Coronary Intervention 
VCI  Virtual Coronary Intervention 
























Using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) improves 
clinical outcomes and reduces costs compared with angiographic guidance
1
. FFR also impacts 
decisions regarding interventional strategy. In the RIPCORD study, knowledge of FFR altered the 
recommended treatment plan in 26% of patients
2
. However, FFR measurement is invasive, 
expensive, time-consuming and not available at all centres.  It therefore remains under-used
3
 
Computational fluid dynamics models of FFR (vFFR) based upon the angiogram can predict FFR 
without the need for invasive instrumentation
4-6
. Related modelling techniques also permit virtual 
coronary intervention (VCI) or ‘virtual stenting’ which enables the physiological response to 
alternative stenting strategies to be predicted a priori
7
. However, it remains unknown whether such 
virtual clinical methods have a similar impact upon clinical decision making as invasive FFR.  
 
In this study, we investigated the effect of the VIRTUheart
TM
 model of vFFR and VCI upon decision 
making for patients with acute or chronic coronary syndromes. 
 
Methods 
Study design and patients 
This was an observational study involving retrospective analysis of prospectively collected data from 
patients attending the cardiac catheter laboratory at the Northern General Hospital, Sheffield, UK; a 
large tertiary cardiac centre in the North of England.  We interrogated the research database to 
identify patients who had undergone PCI for chronic or non-ST-segment elevation acute coronary 




nearly 500 coronary angiograms. These cases have already been pre-screened for their suitability for 
coronary modelling
7
. Seventy consecutive cases from the database, meeting the inclusion criteria 
were selected for analysis. Patients were excluded if they had presented with ST-segment elevation 
myocardial infarction, previous coronary artery bypass graft (CABG) surgery, chronic total coronary 
artery occlusions or if the angiographic images were unsuitable for modelling. From the initial 
seventy, fifty patient cases were identified for inclusion in the study (in keeping with sample size 
calculation below). A patient flow diagram is shown in Supplementary figure S1. The research was 
approved by the NHS Research Ethics Committee and the institutional review board. As this was an 
observational study utilising routinely collected clinical data no formal consent was required.  
 
Original procedure  
Patients underwent standard, multiple single plane coronary angiography prior to PCI. PCI was 
performed using standard techniques according to the operator’s normal practice. Treatment 




Angiograms were screened against the criteria for accurate modelling, namely: adequate image 
centering; at least two orthogonal views; inclusion of the whole arterial segment of interest; 
sufficient contrast between vessel and background; minimal vessel overlap; sufficiently long 
acquisitions to capture several cardiac cycles with at least one good diastolic frame; and minimal 
panning. Vessels with a minimum diameter of 2.5mm and at least 30% diameter stenosis by visual 
estimation were included. Cases which did not meet these criteria were excluded.  Using the 
VIRTUheart
TM




plausible VCI strategies were constructed, based on advice from an independent interventionist 
(figure 3)
 8
. vFFR was computed pre- and post-VCI. 
 
Impact of vFFR and VCI upon clinical decisions 
Cases were independently reviewed by two interventionists blinded to each other and to the original 
procedure.  Each cardiologist was presented with the clinical history, ECG and baseline angiographic 
images. Based upon these conventional data sources, they were asked to give their recommendation 
for treatment (on a per-patient level); optimal medical therapy [OMT], PCI, CABG surgery or ‘more 
information required’, which could include measured FFR or any other investigation they felt was 
required in order for them to make a decision. If they selected PCI, they were asked to specify the 
vessel(s) for revascularisation and the number and size of stent(s) they would recommend based 
upon their clinical practice. At each stage, they were asked to rate their confidence in their decision 
on a scale 0-10 (10 being high). After making the initial recommendations, they were shown the 
results of baseline vFFR modelling (including the stent sizing tool, which displays the vessel width at 
any chosen point as well as the distance between any two pre-specified points along the vessel path 
(supplementary figure S2)) and asked to re-state their management plan and their confidence in the 
decision based upon those additional data. Finally, they were shown the VCI results and, again, were 
asked to state any changes in the management plan. At each stage, the interventional cardiologists 
were asked to utilise the vFFR and VCI data in combination with their own clinical judgment to 
reflect real world practice. The importance they ascribed to the modelling was left to their 
discretion. All of the participating cardiologists were presented with the most recently published 
accuracy data for both vFFR and VCI prior to commencing the study
8
. The study protocol is 
illustrated in Figure 1.  To further explore inter-observer variability, a subset of 12 cases were 




other and of the original clinical team. They were presented in the same way as above. The primary 
outcome was the number/percentage of cases in which the patient-level treatment 
recommendation changed based upon virtual physiology. 
 
 
Analysis and sample size 
Continuous data were presented as mean (±SD) and categorical data as number (percentage) unless 
stated otherwise. Patient-level treatment strategies based upon angiographic, vFFR and VCI 
assessment were compared. Agreeability between operators was assessed using Cohen’s kappa 
coefficient. Confidence scores were compared using repeated measures ANOVA. Statistical analysis 
was carried out using SPSS version 21 (SPSS Inc, New York, US). Based upon the RIPCORD study, it 
was estimated that a change of management would be observed in about 25% of patients; a change 
<10% being deemed unimportant. The number of patients required in the study is directed by p, the 
proportion of cases in which the decision is different after the intervention than it was before. The 
95% confidence intervals for p are derived from the formula: p̂±1.96 √ (p̂(1−p̂)/n). A sample size of 
50 provides 95% confidence intervals of 12% to 37% for this effect size.  
Results   
Patient and vessel characteristics 
 
Patient baseline characteristics are summarised in Table 1. Fifty potentially suitable patients were 
identified from hospital records, with a total of 86 diseased vessels. Eight (9%) vessels were 
unsuitable for vFFR modelling, so 78 lesions were included in the final analysis from 50 patients.  
Cases included 43 left anterior descending (LAD), 17 circumflex (LCX), 13 right (RCA), three diagonal 





Impact of disclosing vFFR result 
After revealing the vFFR results, the operators changed their initial management strategy on 22 
occasions (22%, 95% CI: 15% to 31%). Each patient case is considered twice (as each case was 
reviewed independently by the two operators), therefore ‘occasion’ refers to a particular case 
assessed by an individual operator. Details of the nature of these changes are shown in Figure 2.  PCI 
strategy (number and location of vessels for PCI) changed in a further five (5%), so the total number 
of occasions in which management changed was 27 (27%, 95% CI: 19-36%) (20% of patients for 
operator A and 34% of patients for operator B). In cases where PCI was selected, vFFR resulted in a 
change in stent size in 47%. The amendments comprised an increase in length in 48%, a reduction in 
length in 32%, a reduction in diameter in 32% and an increase in diameter in 10%.  
 
Effect of disclosing VCI results 
For cases in which PCI was recommended, disclosure of the VCI results led to a change in stent size 
in 33% of occasions. The amendments comprised an increase in stent length in 44%, a reduction in 
stent length in 30%, a reduction in stent diameter in 22% and an increase in stent diameter in 4%. 
On one occasion, VCI led to a change in initial strategy. This was a case with a borderline vFFR, 
prompting the cardiologist to recommend an invasive pressure wire. However, VCI revealed an 
excellent result with minimal stenting, which provided sufficient reassurance to proceed with PCI 
without the need for a pressure wire.  
 




Stent size was amended with either vFFR or VCI on 48% occasions. The amendments comprised an 
increase in length in 42%, a reduction in length in 28%, an increase in diameter in 4% and a 
reduction in diameter in 25%. Mean stent widths after angiographic, vFFR and VCI assessments were 
2.91±0.34, 2.85±0.31 and 2.83±0.32 respectively (P=0.04). Mean stent lengths after angiographic, 
vFFR and VCI assessment were 23.0±8.5, 24.2±8.7 and 23.9±8.3 mm, respectively (P=0.37).  
Confidence in the management plan  
Based upon angiographic assessment alone, mean confidence scores in patient-level management, 
vessel-level management and stent sizing were 8.11, 8.38 and 6.94 out of 10, respectively. 
Disclosure of vFFR increased operator confidence in all three domains (patient-level management 
+0.47 ±1.27, P<0.001; vessel-level +0.48 ±1.23, P<0.001; stent sizing +1.0 ±1.14, P<0.001). After VCI 
results were revealed, the confidence level in patient-level management and stent sizing both 
increased significantly (+0.14 ±0.63, P=0.03; +0.72 ±0.62, P<0.001) but there was no significant 
change in confidence in vessel-level management (+0.07 ±0.63, P=0.31). Summarised data are 
shown in Table 2. Confidence in angiography-based management was not related to whether the 
operator went on to change their plan based upon physiology or not (8.18 versus 7.82, P=0.32).  
However, initial confidence in stent size was significantly lower in those cases in which stent size 
recommendation subsequently changed (6.63 versus 7.15, P=0.02). 
 
Inter-observer variability 
The subset of 12 cases reviewed independently by a total of eight interventional cardiologists 
comprised nine LADs, six LCXs and five RCAs. Mean vFFR was 0.73 (±0.15). Baseline characteristics 
are summarised in Table 3. There was minimal agreement between the cardiologists’ management 
plans (k=0.30, 95% CI: 0.21-0.39) either before (ie based upon the angiogram) or after (k=0.39, 95% 






In this study, we have analysed the potential for angiography-based computed coronary physiology, 
namely a virtual FFR (vFFR), with its derivative, virtual coronary intervention (VCI), to alter patient 
management. Knowledge of the baseline vFFR led to a change in management in 27%. VCI led to a 
change in recommended stent size in 48%. Of note, the proportion of cases in which management 
was changed based upon the physiology varied greatly, and when eight cardiologists were studied, 
the proportion of patients in whom changes were recommended varied between none and 50% 
(average 33%). There were also marked differences between their management plans, whether 
based both upon traditional angiography or physiology. However, both vFFR and VCI significantly 
improved the cardiologist’s confidence in their management plans.  
 
Impact of vFFR upon patient management 
When baseline vFFR results were revealed, a change in the proposed management plan occurred in 
27-33% of patients. The effect of revealing coronary physiology upon cardiologists’ decision making 
has previously been examined in the RIPCORD
2
 and FFRCT RIPCORD
9 
trials. In RIPCORD, there was a 
change in the patient-specific management plan in 26% of cases with FFR compared to angiography 
alone, and in FAMOUS it was 22%
10
 remarkably similar proportions to our study. Our study differed 
from RIPCORD and FAMOUS in a number of ways. First, ours included both chronic and acute 
coronary syndromes, reflecting current practice
11
. Second, only patients who had initially been 
selected for PCI were included. This was to ensure there was a high proportion of lesions to assess. 
Third, and most importantly, RIPCORD and FAMOUS used invasive FFR whereas our study used vFFR 
which is not yet as well validated as invasive FFR
12, 13
. Fourth, in our study, the interventional 




fit, based upon the whole clinical, angiographic and physiological setting, without mandating 
treatment based solely upon the FFR, in order to explore the impact of virtual coronary physiology in 
real world practice. This probably explains the wide variation in treatment recommendations 
between individuals when presented with the same vFFR. In acute cases, we found that operators 
frequently chose to proceed to revascularisation irrespective of the vFFR. In the FFRCT RIPCORD 
study, FFRCT changed treatment decisions compared to those made based upon CTCA alone in 36% 
of cases
9
. The single largest group change was from ‘more information required’ (i.e. an invasive 
pressure wire) to either OMT or PCI, constituting 53% of the cases in which management changed. 
This accorded with our findings (70%). In our study, an invasive pressure wire was recommended in 
30% of cases. Whilst this is higher than the observed usage of 5-10%
3
, because this was a virtual 
study, this might not translate into actual pressure wire usage; and in the FFRCT RIPCORD study, the 
equivalent figure was 19%. Moreover, this study was carried out in a tertiary cardiology centre with 
ready access to pressure wire usage.  
Inter-observer variability 
Our initial findings of a large variation in recommendations between our two experts mandated 
further study with a larger group of interventional cardiologists. When the same patient cases were 
reviewed by eight cardiologists, patient-level management changed, based upon vFFR, in 33%, but 
the range was 0-50%; so the impact of vFFR was considerable, but the difference between operators 
was even greater. There was also significant variation between management plans, with minimal 
increase in agreement following vFFR disclosure. Inter-observer variability in assessing coronary 
angiograms is well documented
14-18 
but the impact upon treatment decisions is less well known. In 
our study, a major factor was trust in the vFFR, especially when the 3D reconstruction differed from 
their perception of the angiogram. Despite several studies demonstrating disagreement between 
visual and physiological assessment, many operators believe angiography to be superior. The ERIS 
study
19




fewer cases than recommended, the predominant reason being confidence in the history and the 
angiogram. We found that the operators’ initial confidence in their management plan was unrelated 
to their decision according with physiology or whether they went on to change their plan based 
upon physiology. This suggests that being confident in angiographic assessment is not a good reason 
to refrain from physiological assessment. In our study, in an average of 38%, after vFFR was made 
available, the management plan still contradicted what would be recommended by vFFR alone. The 
most common reason for this (33%) was the presence of other clinical or technical factors that 
precluded PCI, such as diffuse disease, distal disease, or non-invasive imaging confirming non-
viability. However, in 22% of cases, the operator stated that they were more convinced by their 
angiographic assessment than the vFFR.  
Impact of VCI upon treatment planning 
Although disclosure of the VCI results had little impact upon patient-level management beyond that 
achieved with vFFR, the procedural details (size of stent) changed in 33% of cases based upon VCI 
alone, and in 48% when combined with the stent sizing feature. VCI is intended to be a treatment 
planning tool, so its main use is in cases in which the operator has already decided that PCI is 
warranted, based upon either angiographic or physiological assessment. VCI then allows the 
operator to plan the procedure more precisely. We have demonstrated, for the first time, that this 
approach has the potential to significantly impact treatment decisions. This could maximise 
physiological benefit from PCI, potentially leading to improved outcomes, and possibly reduce the 
risks of over- or under- sizing and excessive stent length. This concept needs to be explored. In 
addition, vFFR allied to VCI may offer the non-interventional cardiologist appreciation of the 
possibilities for treatment. Previous work demonstrates that VCI based on invasive pressure wire 







Clinical applicability in the future 
For the purpose of this study, vFFR and VCI were performed in all cases regardless of complexity. In 
reality, not all cases will require vFFR and/or VCI and determining when these should be used 
remains an important question. A severe lesion, or a completely normal vessel does not warrant 
vFFR. Its benefit, like invasive FFR, is in moderate lesions where the haemodynamic significance is 
unclear. However, correctly identifying these cases remains challenging. The purpose of VCI is for 
treatment planning, so it is most relevant in cases where the operator is unsure on the optimal 
stenting strategy regardless of the baseline vFFR (eg one versus multiple stents in the setting of 
diffuse or tandem lesions). Ultimately it will be up to the operator when they wish to utilise these 
technologies, therefore more work is required to provide outcome data and convince cardiologists 
that a virtual physiology based approach is superior to an angiography based approach. Significant 
variation in the confidence in the virtual technology, when it disagreed with the operators own 
angiographic assessment, was a key contributor to the inter-observer variability demonstrated in 
this study.  
 
Limitations 
First, only patients undergoing PCI were studied. We could not assess the potential impact upon a 
wider group of patients with coronary disease. Second, the sample was relatively small. Third, stent 
sizing decisions were made without the aid of balloon markers, intravascular imaging or other cues, 
which would normally be available to assist the operator with sizing during the invasive procedure. 
Fourth, vFFR was computed using generic boundary conditions, although previous work has 
demonstrated acceptable accuracy with this method. All operators were advised of the accuracy of 
the tools before they began their assessment. Fifth, in a virtual study with modest numbers we 




treatment recommendations based upon the real-life practice; but as this was a virtual study, it was 
not possible to control for potential bias. Seventh, this was not an all-comers study; cases were 
selected from a pre-screened research database. We have previously reported that the proportion 
of ‘real-world’ cases that are suitable for coronary modelling is about 80%7. Eighth, our cases include 
a higher proportion of LAD arteries than LCX and RCA due to a slightly higher exclusion rate of these 
arteries due to difficulties with the 3D reconstruction. The LAD is generally well imaged in multiple 
views and its course tends to be less torturous which permits more accurate segmentation (3D 
reconstruction). The RCA is more challenging because it typically traverses multiple planes which 
makes the selection of truly orthogonal views more challenging. Moreover, often only two images of 
the RCA are routinely acquired so there are no alternative images available if one is unsuitable. 
However, the software is continually being updated to overcome these issues. A larger study would 
be required to determine the true magnitude of this effect. 
 
Conclusion 
Disclosure of vFFR can lead to a change in planned patient management in about a third of cases 
compared to angiography-based assessment. Combining our novel stent sizing tool with VCI resulted 
in change in recommended stent sizing in almost half. Virtual physiology and VCI increased operator 
confidence in their selected treatment strategy. However, the treatment plans, and how virtual 
physiology was incorporated into them, varied significantly between interventional cardiologists.  
Our findings suggest that virtual physiology has the potential to alter management; but, as with 
measured indices, it remains the interventional cardiologist who places this into the context of the 
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Table 1: Patient and lesion characteristics 
 
 
Patient characteristics (N=50) 
Mean age (years) 66 ± 11 
Male 36 (72%) 
Hypertension 33 (66%) 
Hyperlipidaemia 20 (40%) 
T2DM 12 (24%) 
Current smoker 12 (24%) 
Previous MI 6 (12%) 
 
Indication for PCI:  




NSTEMI 33 (66%) 
Vessel characteristics (N=64) 
Vessel  
LAD 37 (58%) 
LCX 14 (22%) 
RCA 10 (16%) 
OM 2 (3%) 
Dx 1 (2%) 
Baseline vFFR 0.73 ± 0.16 
No. of stents 1.1 ± 0.3 
Mean stent length (mm) 21.3 ± 7.4 
Mean stent width (mm) 3.1 ± 0.4 
Dx – Diagonal artery, LAD = Left anterior descending artery, LCX = Left Circumflex artery, MI = Myocardial Infarction, NSTEMI = No n ST Elevation Myocardial 









Table 2. Confidence scores in patient-level management, vessel-level management and 
stent sizing following angiographic assessment, vFFR assessment and VCI (scale 1-10).  
 Angio vFFR VCI P value 
Cardiologist A 
Patient level 8.64±1.38 8.76±1.35 8.86±1.31 0.04 
Vessel level 9.21±0.95 9.21±1.01 9.25±0.87 0.52 
Stent size 7.34±1.03 7.92±0.91 8.62±0.91 <0.001 
Cardiologist B 
Patient level 7.58±1.43 8.22±1.17 8.39±0.92 <0.001 
Vessel level 7.59±1.48 8.29±1.24 8.38±1.04 <0.001 
Stent size 6.56±0.73 7.72±0.95 8.42±0.84 <0.001 
Combined 
Patient level 8.11±1.50 8.49±1.29 8.63±1.15 <0.001 
Vessel level 8.38±1.48 8.71±1.23 8.79±1.06 <0.001 
Stent size 6.94±0.97 7.81±0.94 8.51±0.88 <0.001 
Values = Mean ± SD. vFFR = Virtual Fractional Flow Reserve; VCI = Virtual Coronary Intervention. P 
















Table 3: Baseline patient and vessel characteristics for the subset of 12 patients 
Patient characteristics (N=12) 
Mean age (years) 64±10 
Male 8(67%) 
Hypertension 7 (58%) 
Hyperlipidaemia 5 (42%) 
T2DM 1 (8%) 
Current smoker 4 (33%) 
Previous MI 2 (17%) 
 
Indication for PCI:  
Stable angina 4 (33%) 
NSTEMI 8 (67%) 
Vessel characteristics (N=20) 
Vessel  
LAD 9 (45%) 
LCX 6 (30%) 
RCA 5 (25%) 
Baseline vFFR 0.73 ± 0.15 
Values are mean ± SD or number (%). LAD = Left Anterior Descending; LCX = Left Circumflex; MI = 
Myocardial Infarction; NSTEMI = Non-ST-Elevation Myocardial Infarction; PCI = Percutaneous 
Coronary Intervention; RCA = Right Coronary Artery; T2DM = Type 2 Diabetes Mellitus; vFFR = Virtual 



















Table 4: Recommended management plans provided by cardiologists for a subset of 12 patients 
after angiographic assessment and vFFR assessment. 
 
A B C D E F G H 
Ang FFR Ang FFR Ang FFR Ang FFR Ang FFR Ang FFR Ang FFR Ang FFR 
1                                 
2                                 
3                                 
4                                 
5                                 
6                               
7                                 
8                                 
9                                 
10                                 
11                                 
12                                 
  
  
   
     
 
 
Twelve patient cases (1-12) were reviewed by eight cardiologists (A-H). For each case, the 
cardiologist provided a management plan (OMT, PCI, CABG or more information required) based 
upon conventional angiography (column Ang). A second plan was then made after vFFR results were 

























Table 5: Case example: Breakdown of management plans made by each cardiologist after angiographic, vFFR and VCI assessment. 
 
 Angiographic vFFR VCI 
Cardiologist Plan Vessel(s) for PCI Stent size Plan Vessel(s) for PCI Stent size Plan Vessel(s) for PCI Stent size 
A OMT  - OMT  - OMT  - 





2.25 x 32mm, 
2.75 x 32 mm 






2.25 x 32mm, 
2.75 x 32 mm 
2.5 x 28mm 
C PCI  RCA 3.0 x 48mm PCI  RCA 3.0 x 48mm PCI  RCA 3.0 x 48mm 
D PCI and PW LCX RCA 2.5mm x 30mm PCI RCA 2.5 x 38mm PCI RCA 2.5 x 38mm 
E PW LAD, if +ve 
surgical referral 
- - PCI  RCA 2.75 x 30mm PCI  RCA 2.75 x 30mm 
F OMT  - OMT  - OMT  - 
G PW LAD, if +ve 
surgical referral 




H PCI  RCA 3.0 x 38mm PCI  RCA 3.0 x 38mm PCI  RCA 3.0 x 38mm 














Figure 2: Summary of management plans made after angiographic and vFFR 
assessment  
Detailed breakdown of management plan allocation by angiography alone and after vFFR 
assessment.  
 
Figure 3: Illustrative case example 
A 78-year-old female with a background of T2DM and hypertension attended A&E with severe chest 
tightness. The troponin was >10x ULN. There were no localising features on ECG. Baseline 
angiographic images of the LAD, LCX and RCA are shown in the top left, centre and right panels 
respectively above the corresponding vFFR and VCI results. Up to four VCI strategies are shown for 
each vessel (selected after consultation with an independent interventional cardiologist). For each, 
the reconstructed artery is displayed as well as the predicted post treatment vFFR. The stent details 
are displayed above the image. The operators’ management plans based upon angiographic, vFFR 
and VCI assessment are shown in Table 5.  
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